Cardiovascular Outcomes associated With adult Electronic Cigarette Use.
Population Clinical
Population Health Impact
Vindhyal (2020)
Dermatologic manifestations associated with electronic cigarette use.
Individual Clinical
Safety
Adverse Effects
Visconti (2019)
Improving the analysis of E-Cigarette Emissions: Detecting human “Dry Puff” Conditions in a Laboratory as Validated by a Panel of Experienced Vapers.
Nonclinical
Chemical
Methods
Visser (2021)
Impairment of testicular function in electronic cigarette (e-cig, e-cigs) exposed rats under low-voltage and nicotine-free conditions.
Nonclinical
Reproductive & Developmental Effects
In Vivo
Vivarelli (2019)
On the toxicity of e-cigarettes consumption: Focus on pathological cellular mechanisms.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Vivarelli (2022)
Comparative cytotoxicity study of nicotine and cotinine on MRC-5 cell line
Nonclinical
Cytotoxicity
Vlasceanu (2018)
adolescents’ e-cigarette use: Increases in frequency, dependence, and nicotine exposure over 12 months.
Population Clinical
Consumer Use
Youth Use & Appeal
Vogel (2019)
Measuring e-cigarette addiction among adolescents.
Individual Clinical
Biomarkers
Biomarkers Of Harm
Vogel (2020)
Prevalence of Electronic Cigarette Dependence among Youth and Its association With Future Use.
Population Clinical
Consumer Use
Youth Use & Appeal
Vogel (2020)
Young people’s e-cigarette risk perceptions, policy attitudes, and past-month nicotine vaping in 30 U.S. cities.
Population Clinical
Consumer Use
Youth Use & Appeal
Vogel (2021)